|
Cerus Corp. - cerus.com
Develops systems designed to improve safety of blood transfusions by inactivating infectious pathogens in blood components, platelets, fresh frozen plasma and red blood cells, and to inhibit leukocyte activity. Details of system and company based in Concord, California. (Nasdaq: CERS)
cerus helinx replication blood intercept transfusion platelets plasma red blood cells
|